Seliciclib (R-roscovitine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Seliciclib (R-roscovitine), covering 2025-09-11 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease [Phase 2]